Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

Patients with type 2 diabetes who use semaglutide have more than double the risk of severe optic nerve damage than those who ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

Nestle just rolled out a new protein shot drink that it says will help people looking to lose weight manage their hunger and ...

Ozempic (semaglutide) is prescribed for adults with ... Ozempic is given as a weekly dose. Each pen has several doses. The number of doses will depend on the dosage that your doctor recommends ...

Ozempic (semaglutide) is an injectable, prescription-only medication that suppresses appetite and slows down digestion. Here, ...

Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two ...

The U.S. Food and Drug Administration announced Thursday that the shortage of tirzepatide — the active ingredient in Eli ...

A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.

Research shows that patients who stop taking semaglutide – the active ingredient in Ozempic and Wegovy – on average regain about two-thirds of their weight. However, patients who lose a large ...

The first report to describe NAION as a suspected adverse reaction to semaglutide—the active ingredient in both Ozempic and Novo’s Wegovy—was received in July. NAION happens when blood flow ...

Study authors point to semaglutide medication and “behavior changes” as a possible cause for the shift Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in ...